DAIC

FEBRUARY 29, 2024

ET Main Tent (Hall B1) - A Double-blind, Randomized Placebo Procedure-controlled Trial of an Interatrial Shunt in Patients with HFrEF and HFpEF: Principal Results From the RELIEVE-HF Trial - Empagliflozin After Acute Myocardial Infarction: Results of the EMPACT-MI Trial - CSL112 (Apolipoprotein A-I) Infusions and Cardiovascular Outcomes in Patients (..)

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Journal of the American Heart Association

DECEMBER 20, 2024

BackgroundCardiogenic shock complicating acute myocardial infarction is associated with a high mortality rate. Cardiogenic shock after outofhospital cardiac arrest (OHCA) can be due to transient myocardial stunning but also reflect the increasing severity of ongoing heart failure.

Cardiac Arrest 45

Cardiac Arrest Cardiogenic Shock Hospital Myocardial Infarction 45

Dr. Smith's ECG Blog

NOVEMBER 19, 2016

Authors' commentary: Cardiogenic shock in the setting of severe aortic stenosis. This patient’s severe aortic stenosis (AS) and associated severe cardiogenic shock likely created the ECG pattern, resulting in a very difficult challenge for our inpatient team. If you can use Doppler, then you can diagnose it.

Ischemia 40

Ischemia Cardiogenic Shock Aortic Stenosis 40

Journal of the American Heart Association

MARCH 7, 2025

Journal of the American Heart Association, Ahead of Print. BackgroundPatients with severe mitral regurgitation and cardiogenic shock demonstrate a poor prognosis. Stroke, myocardial infarction, and heart failure hospitalization rates were 2% (95% CI, 1%2%), 15% (95% CI, 13%18%), and 9% (95% CI, 8%10%), respectively.

Cardiogenic Shock 45

Cardiogenic Shock Bicuspid/Mitral Myocardial Infarction Heart Failure 45

European Journal of Heart Failure

FEBRUARY 16, 2025

Organ perfusion pressure as a predictor of outcomes in cardiogenic shock: insights from the Altshock-2 registry. ABSTRACT Aims The diagnosis of cardiogenic shock (CS) relies upon signs and/or symptoms of end-organ hypoperfusion. The primary outcome was in-hospital all-cause mortality.

Cardiogenic Shock 40

Cardiogenic Shock Outcomes Myocardial Infarction Heart Failure 40

European Journal of Heart Failure

FEBRUARY 23, 2024

Cardiogenic shock is a primary cardiac disorder that results in both clinical and biochemical evidence of tissue hypoperfusion and can lead to multi-organ failure and death depending on its severity. Despite some advances in cardiogenic shock management, this clinical syndrome is still burdened by an extremely high mortality.

Cardiogenic Shock 75

Cardiogenic Shock Myocardial Infarction Article 75

Circulation: Heart Failure

MARCH 5, 2025

Circulation: Heart Failure, Ahead of Print. BACKGROUND:There are limited large-scale data on the outcomes of patients with cardiogenic shock (CS) transferred to hub centers.

Cardiogenic Shock 56

Cardiogenic Shock Hospital Outcomes Myocardial Infarction 56

Frontiers in Cardiovascular Medicine

JULY 22, 2024

IntroductionIn developing countries, there is a notable scarcity of real-world data on adherence to optimal medical therapy (OMT) and its correlation with major cardiovascular adverse events (MACEs) after ST-elevation myocardial infarction (STEMI). Patients were followed up for 4.5 ResultsWe included 349 patients with a mean age of 58.08

Myocardial Infarction 59

Myocardial Infarction Risk Factors Cardiogenic Shock STEMI 59

European Journal of Heart Failure

JANUARY 17, 2025

Predictors of weaning failure from veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in patients with cardiogenic shock. The cause of CS was acute myocardial infarction in 438 (63.9%) patients, and 431 (62.9%) patients presented with cardiac arrest. RRT, renal replacement therapy.

Cardiogenic Shock 66

Cardiogenic Shock Cardiac Arrest Myocardial Infarction Hospital 66

European Journal of Heart Failure

DECEMBER 12, 2023

Abstract Objectives This study aimed to assess the impact of anemia and iron deficiency (ID) on clinical outcome in patients with cardiogenic shock (CS) complicating acute myocardial infarction (AMI). Nevertheless, data concerning the impact of anemia and ID on clinical outcome in patients with CS are scarce.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Outcomes Catheterization Laboratory 40

Circulation: Cardiovascular Interventions

FEBRUARY 20, 2024

BACKGROUND:Patients with ST-segment–elevation myocardial infarction but no coronary microvascular injury are at low risk of early cardiovascular complications (ECC). CONCLUSIONS:NH-IMRangiois a valuable risk-stratification tool in patients with ST-segment–elevation myocardial infarction.

Myocardial Infarction 40

Myocardial Infarction STEMI Cardiogenic Shock Cardiac Arrest 40

Open Heart

OCTOBER 7, 2024

Background Takotsubo cardiomyopathy (TC) is an established differential diagnosis of myocardial infarction with non-obstructive coronaries with significant interest but limited data on prognostication. to 7.09), p<0.001) and chronic heart failure (OR 1.60 (95% CI 1.54 for other ACS) in-hospital mortality events.

Inpatient 52

Inpatient Coronary Artery Bypass Graft Cardiomyopathy Cardiogenic Shock 52

Journal of the American Heart Association

MARCH 21, 2025

We evaluated the association between social vulnerability and a composite of myocardial infarction, stroke, heart failure, venous thromboembolism, cardiogenic shock, cardiac arrest, and death, following discharge, using Cox regression models.

COVID-19 40

COVID-19 Medicare Hospital Cardiogenic Shock 40

Dr. Smith's ECG Blog

NOVEMBER 12, 2020

Assessment was severe sudden cardiogenic shock. Clin Chem [Internet] 2020;Available from: [link] Smith mini-review: Troponin in Emergency Department COVID patients Cardiac Troponin (cTn) is a nonspecific marker of myocardial injury. Myocardial Infarction Type 2 and Myocardial Injury. What is it?

Cardiac Arrest 52

Cardiac Arrest COVID-19 Myocardial Infarction Cardiogenic Shock 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Adult Cardiac Surgery Database Lead Author Title Publication Date Jacob Raphael Red Blood Cell Transfusion and Pulmonary Complications: The Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis The Annals of Thoracic Surgery January 2024 Joseph Sabik Multi-Arterial versus Single-Arterial Coronary Surgery: Ten Year Follow-up of One Million (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Program Designations Access and Publications (A&P) 1 Participant User File (PUF) 2 Task Force on Funded Research (TFR) 3 Special Projects 4 Adult Cardiac Surgery Database Lead Author Title Publication Date William Keeling 2 National Trends in Emergency Coronary Artery Bypass Grafting European Journal of Cardiothoracic Surgery October 2023 Jake (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Open Heart

DECEMBER 26, 2023

Methods A large-scale cohort study of patients with ST-elevation/non-ST-elevation myocardial infarction (MI)/unstable angina underwent coronary angiography (January 2015–December 2019). Patients were classified as older (≥75 years) and younger (≤74 years). vs 86.2%, p<0.001).

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Outcomes Angina 40